One month on from the start of Russia’s invasion of Ukraine on 24 February, relief efforts are progressing across the off-patent industry as the conflict continues.
Regional generics and biosimilars association Medicines for Europe has highlighted that the supply of medicines is “critical yet unstable as war continues in Ukraine,” urging “special effort and protection” from European heads of state and governments,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?